These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25116888)

  • 1. Pharmacological consequences of inhaled drug delivery to small airways in the treatment of asthma.
    Bodzenta-Łukaszyk A; Kokot M
    Adv Ther; 2014 Aug; 31(8):803-16. PubMed ID: 25116888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are we overlooking persistent small airways dysfunction in community-managed asthma?
    Anderson WJ; Zajda E; Lipworth BJ
    Ann Allergy Asthma Immunol; 2012 Sep; 109(3):185-189.e2. PubMed ID: 22920073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of the long-acting beta-adrenergic bronchodilators in the treatment of asthma.
    Mansfield LE
    Allergy Asthma Proc; 2008; 29(2):103-8. PubMed ID: 18430306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real life clinical study design supporting the effectiveness of extra-fine inhaled beclomethasone/formoterol at the level of small airways of asthmatics.
    Popov TA; Petrova D; Kralimarkova TZ; Ivanov Y; Popova T; Peneva M; Odzhakova T; Ilieva Y; Yakovliev P; Lazarova T; Georgiev O; Hodzhev V; Hodzheva E; Staevska MT; Dimitrov VD
    Pulm Pharmacol Ther; 2013 Dec; 26(6):624-9. PubMed ID: 23769863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New asthma drugs: small molecule inhaled corticosteroids.
    Gentile DA; Skoner DP
    Curr Opin Pharmacol; 2010 Jun; 10(3):260-5. PubMed ID: 20561819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do inhaled corticosteroid/long-acting beta2-agonist fixed combinations provide superior clinical benefits compared with separate inhalers? A literature reappraisal.
    Barnes PJ; Nicolini G; Bizzi A; Spinola M; Singh D
    Allergy Asthma Proc; 2012; 33(2):140-4. PubMed ID: 22525390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
    Diamant Z; Dekhuijzen PN
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asthma therapy with aerosols: clinical relevance for the next decade.
    Barnes PJ
    J Aerosol Med; 1996; 9(1):131-41. PubMed ID: 10160203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic interventions to reduce the risk of asthma exacerbations.
    O'Byrne PM
    Proc Am Thorac Soc; 2004; 1(2):105-8. PubMed ID: 16113421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why particle size should affect clinical response to inhaled therapy.
    Howarth PH
    J Aerosol Med; 2001; 14 Suppl 1():S27-34. PubMed ID: 11424890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New combination therapies for asthma.
    Donohue JF; Ohar JA
    Curr Opin Pulm Med; 2001 Mar; 7(2):62-8. PubMed ID: 11224725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of asthma in resource-limited settings: role of low-cost corticosteroid/β-agonist combination inhaler.
    Chiang CY; Aït-Khaled N; Bissell K; Enarson DA
    Int J Tuberc Lung Dis; 2015 Feb; 19(2):129-36. PubMed ID: 25574908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic approach to the distal airways in asthma].
    de Diego Damiá A; Vega Chicote JM
    Arch Bronconeumol; 2011 Apr; 47 Suppl 2():27-31. PubMed ID: 21640282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic novelties of inhaled corticosteroids and bronchodilators in asthma.
    Ricciardolo FL; Blasi F; Centanni S; Rogliani P
    Pulm Pharmacol Ther; 2015 Aug; 33():1-10. PubMed ID: 26014510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy of bronchial asthma.
    Nelson HS
    Allergy Asthma Proc; 2001; 22(4):217-20. PubMed ID: 11552671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balancing safety and efficacy in pediatric asthma management.
    Skoner DP
    Pediatrics; 2002 Feb; 109(2 Suppl):381-92. PubMed ID: 11826254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing compliance with inhaled corticosteroids through the use of combination therapy.
    Holt S; Masoli M; Beasley R
    J Allergy Clin Immunol; 2004 Feb; 113(2):219-20. PubMed ID: 14767433
    [No Abstract]   [Full Text] [Related]  

  • 18. Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life Studies.
    Sonnappa S; McQueen B; Postma DS; Martin RJ; Roche N; Grigg J; Guilbert T; Gouder C; Pizzichini E; Niimi A; Phipatanakul W; Chisholm A; Dandurand RJ; Kaplan A; Israel E; Papi A; van Aalderen WMC; Usmani OS; Price DB
    J Allergy Clin Immunol Pract; 2018; 6(3):907-915.e7. PubMed ID: 28941668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extra-fine particle inhaled corticosteroids, pharma-cokinetics and systemic activity in children with asthma.
    Wolthers OD
    Pediatr Allergy Immunol; 2016 Feb; 27(1):13-21. PubMed ID: 26360937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting small airways in asthma: improvement in clinical benefit?
    Ulrik CS; Lange P
    Clin Respir J; 2011 Jul; 5(3):125-30. PubMed ID: 21106032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.